SEC Form 3 · accession 0001703807-26-000005
Health Catalyst, Inc. · HCAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Simeon Kohl
Officer — Chief Executive Officer · Director
Period of report
Sep 14, 2026
Accepted (ET)
Sep 16, 2026 · 4:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001636422
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 25,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On September 11, 2026, Reporting Person acquired an aggregate of 25,000 shares of the Issuer's common stock through open market purchase with a weighted average price of $1.76427 per share.